SGP
SpyGlass Pharma Inc. Common Stock (SGP)
Healthcare • NASDAQ • $23.41-7.80%
- Symbol
- SGP
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $23.41
- Daily Change
- -7.80%
- Market Cap
- $782.52M
- Trailing P/E
- N/A
- Forward P/E
- -12.21
- 52W High
- $32.44
- 52W Low
- $20.15
- Analyst Target
- $45.00
- Dividend Yield
- N/A
- Beta
- N/A
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.
Company websiteResearch SGP on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.